Professor Jeremy Chapman

OAM
Clinical Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

Telephone +61 2 9845 6349
Fax +61 2 98458300

Map

Selected grants

2013

  • Building partnerships between the Sydney Medical School and universities in Hong Kong and Singapore for collaborative cross-cultural research and training in organ donation; Tong A, Chapman J, Craig J, Wong G, Li P, Kee T; DVC International/IPDF Grant.
  • Investigating barriers and disparities in kidney transplantation; Tong A, Chapman J, Craig J; Kidney Health Australia/Project Grant.

2003

  • Non immunological barriers to successful treatment of diabetes by xenotransplantation?; Hawthorne W, Allen R, O'Connell P, Chapman J, Moran C; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Buell, J., Shores, N., Gross, T., Chapman, J., Webster, A. (2014). Post-Transplant Lymphoproliferative Disorder. In James Neuberger, James Ferguson and Philip N. Newsome (Eds.), Liver Transplantation: Clinical Assessment and Management, (pp. 325-336). Oxford: John Wiley & Sons.
  • Singhai, P., Chapman, J. (2013). Tacrolimus: A Clinician's Perspective on What is Important. In Dimitrios Raptis, Manousos-Georgios Pramateftakis (Eds.), Tacrolimus: Effectiveness, Safety and Drug Interactions, (pp. 41-71). New York: Nova Science Publishers.

Journals

  • Lim, W., Turner, R., Chapman, J., Ma, M., Webster, A., Craig, J., Wong, G. (2014). Acute Rejection, T-Cell-Depleting Antibodies, and Cancer After Transplantation. Transplantation, 97(8), 817-925. [More Information]
  • Huang, J., Zheng, S., Liu, Y., Wang, H., Chapman, J., O'Connell, P., Millis, M., Fung, J., Delmonico, F. (2014). China organ donation and transplantation update: the Hangzhou Resolution. Hepatobiliary & Pancreatic Diseases International, 13(2), 122-124. [More Information]
  • Chapman, J., Lynch, S. (2014). Donor-transmitted, donor-derived, and de novo cancer after liver transplant. Experimental and Clinical Transplantation, 12(Suppl 1), 50-54. [More Information]
  • Chung, R., Howard, K., Craig, J., Chapman, J., Turner, R., Wong, G. (2014). Economic evaluations in kidney transplantation: frequency, characteristics, and quality-a systematic review. Transplantation, 97(10), 1027-1033. [More Information]
  • Ralph, A., Chapman, J., Gillis, J., Craig, J., Butow, P., Howard, K., Irving, M., Sutanto, B., Tong, A. (2014). Family perspectives on deceased organ donation: thematic synthesis of qualitative studies. American Journal of Transplantation, 14(4), 923-935. [More Information]
  • Nguyen, H., Wong, G., Howard, K., Claas, F., Craig, J., Fidler, S., D'Orsogna, L., Chapman, J., Irish, A., Ferrari, P., et al (2014). Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients. Transplantation, 97(7), 769-774. [More Information]
  • Wong, G., Lim, W., Chapman, J. (2014). Questioning the Myth: Benefits of Renin-Angiotensin System Blockade in Kidney Transplant Recipients. Transplantation, 97(3), 271-272. [More Information]
  • Chapman, J., Rangan, G. (2013). Are Nonesterified Fatty Acids Protective in Chronic Allograft Nephropathy? Transplantation, 95(11), 1313-1314. [More Information]
  • Carroll, R., Chapman, J. (2013). Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors? American Journal of Kidney Diseases, 61(5), 698-700. [More Information]
  • Chapman, J., Webster, A., Wong, G. (2013). Cancer in the Transplant Recipient. Cold Spring Harbor Perspectives in Medicine, 3(7), 1-15. [More Information]
  • Chapman, J. (2013). China and the organ trade. Medical Journal of Australia, 199(11), 728. [More Information]
  • Tait, B., Susal, C., Gebel, H., Nickerson, P., Zachary, A., Claas, F., Reed, E., Bray, R., Campbell, P., Chapman, J., Webster, A., et al (2013). Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation, 95(1), 19-47. [More Information]
  • Xiao, D., Craig, J., Chapman, J., Dominguez-Gil, B., Tong, A., Wong, G. (2013). Donor Cancer Transmission in Kidney Transplantation: A Systematic Review. American Journal of Transplantation, 13(10), 2645-2652. [More Information]
  • Chapman, J. (2013). Editorial. Transplantation Reviews, 27(2), 37-37. [More Information]
  • Chadban, S., Eris, J., Russ, G., Campbell, S., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thomson, N., Hutchison, B., et al (2013). Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients. Nephrology, 18(1), 63-70. [More Information]
  • Sparke, C., Moon, L., Green, F., Mathew, T., Cass, A., Chadban, S., Chapman, J., Hoy, W., McDonald, S. (2013). Estimating the Total Incidence of Kidney Failure in Australia Including Individuals Who Are Not Treated by Dialysis or Transplantation. American Journal of Kidney Diseases, 61(3), 413-419. [More Information]
  • Didsbury, M., McGee, R., Tong, A., Craig, J., Chapman, J., Chadban, S., Wong, G. (2013). Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Transplantation, 95(5), 679-687. [More Information]
  • Wong, G., Li, M., Howard, K., Hua, D., Chapman, J., Bourke, M., Turner, R., Tong, A., Craig, J. (2013). Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrology, Dialysis, Transplantation, 28(4), 917-926. [More Information]
  • Essue, B., Wong, G., Chapman, J., Li, Q., Jan, S. (2013). How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrology, 14(1), 1-9. [More Information]
  • Tong, A., Chapman, J., Wong, G., Craig, J. (2013). Living Kidney Donor Assessment: Challenges, Uncertainties and Controversies Among Transplant Nephrologists and Surgeons. American Journal Of Transplantation, 13(11), 2912-2923. [More Information]
  • Garcia, M., Chapman, J., Shaw, P., Gottlieb, D., Ralph, A., Craig, J., Tong, A. (2013). Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biology of Blood and Marrow Transplantation, 19(7), 1046-1058. [More Information]
  • Ho, E., Wong, G., Craig, J., Chapman, J. (2013). Once-Daily Extended-Release Versus Twice-Daily Standard-Release Tacrolimus in Kidney Transplant Recipients: A Systematic Review. Transplantation, 95(9), 1120-1128. [More Information]
  • Danovitch, G., Chapman, J., Capron, A., Levin, A., Abbud-Filho, M., Al Mousawi, M., Bennett, W., Budiani-Saberi, D., Couser, W., Dittmer, I., et al (2013). Organ Trafficking and Transplant Tourism: The Role of Global Professional Ethical Standards - The 2008 Declaration of Istanbul. Transplantation, 95(11), 1306-1312. [More Information]
  • Chapman, J., Marriott, D., Chen, S., Macdonald, P. (2013). Post-transplant pneumocystis jirovecii pneumonia-a re-emerged public health problem? Kidney International, 84(2), 240-243. [More Information]
  • Tong, A., Chapman, J., Wong, G., Josephson, M., Craig, J. (2013). Public Awareness and Attitudes to Living Organ Donation: Systematic Review and Integrative Synthesis. Transplantation, 96(5), 429-437. [More Information]
  • Tong, A., Chapman, J., Israni, A., Gordon, E., Craig, J. (2013). Qualitative Research in Organ Transplantation: Recent Contributions to Clinical Care and Policy. American Journal of Transplantation, 13(6), 1390-1399. [More Information]
  • Mohandas, J., Kumar, A., Ranganathan, D., Healy, H., Huang, Y., O’Loughlin, B., Chapman, J., John, G. (2013). Splenunculus Masquerading as a Neuroendocrine Tumor of the Pancreatic Allograft in a Kidney Pancreas Recipient. Transplantation, 96(8), e59-e62. [More Information]
  • Myint, T., Turner, R., Craig, J., Cross, N., Kable, K., Nankivell, B., Chapman, J., Webster, A., O'Connell, P., Dwyer, D., Jeoffreys, N., Wong, G., et al (2013). Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients. Clinical Transplantation, 27(5), 571-579. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2013). The global role of kidney transplantation. Nephrology, Dialysis, Transplantation, 28(8), e1-e5. [More Information]
  • Wong, G., Turner, R., Chapman, J., Howell, M., Lim, W., Webster, A., Craig, J. (2013). Time on Dialysis and Cancer Risk After Kidney Transplantation. Transplantation, 95(1), 114-121. [More Information]
  • Gordon, S., Nivison-Smith, I., Szer, J., Chapman, J. (2013). Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective. Internal Medicine Journal, 43(11), 1183-1190. [More Information]
  • Chapman, J. (2012). Balancing sensitivity and specificity - unfolding crossmatch biology in renal transplantation*. Transplant International, 25(11), 1129-1130. [More Information]
  • Batabyal, P., Chapman, J., Wong, G., Craig, J., Tong, A. (2012). Clinical Practice Guidelines on Wait-Listing for Kidney Transplantation: Consistent and Equitable? Transplantation, 94(7), 703-713. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Hua, D., Howard, K., Craig, J., Chapman, J., Wong, G. (2012). Cost-Effectiveness of Cidofovir Treatment of Polyomavirus Nephropathy in Kidney Transplant Recipients. Transplantation, 93(2), 188-194. [More Information]
  • Chapman, J., Nalesnik, M. (2012). Despite the Best Intentions Cancer Is Transmissible by Transplantation. Transplantation, 94(12), 1185-1186. [More Information]
  • Chapman, J. (2012). Do protocol transplant biopsies improve kidney transplant outcomes? Current Opinion In Nephrology And Hypertension, 21(6), 580-586. [More Information]
  • Thwaites, S., Gurung, B., Yao, J., Kable, K., Robertson, P., Ryan, B., Lam, V., Pleass, H., Chapman, J., Hawthorne, W., Allen, R. (2012). Excellent Outcomes of Simultaneous Pancreas Kidney Transplantation in Patients From Rural and Urban Australia: A National Service Experience. Transplantation, 94(12), 1230-1235. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). Global role of kidney transplantation. Hong Kong Journal of Nephrology. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Cowley, M., Weinberg, A., Zammit, N., Walters, S., Hawthorne, W., Loudovaris, T., Thomas, H., Kay, T., Gunton, J., Alexander, S., O'Connell, P., et al (2012). Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplantation, 21(9), 2063-2078. [More Information]
  • Rudge, C., Matesanz, R., Delmonico, F., Chapman, J. (2012). International practices of organ donation. British Journal of Anaesthesia, 108(Suppl 1), i48-i55. [More Information]
  • Ezzatzadegan, S., Chen, S., Chapman, J. (2012). Invasive Fungal Infections after Renal Transplantation. International Journal of Organ Transplantation Medicine, 3(1), 18-25.
  • Williams, N., Tong, A., Howard, K., Chapman, J., Craig, J., Wong, G. (2012). Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer. Nephrology, 17(3), 300-306. [More Information]
  • Wong, G., Chapman, J., Craig, J., Chapman, J. (2012). mTOR inhibitors: a myth, a cure for cancer or something in between? American Journal of Transplantation, 12(5), 1075-1076. [More Information]
  • Clayton, P., McDonald, S., Chapman, J., Chadban, S. (2012). Mycophenolate Versus Azathioprine for Kidney Transplantation: A 15-Year Follow-Up of a Randomized Trial. Transplantation, 94(2), 152-158. [More Information]
  • Chapman, J., Alexander, S. (2012). The Candle Illuminating the Pathway to Tolerance? American Journal of Kidney Diseases, 60(4), 521-523. [More Information]
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). The experiences of commercial kidney donors: thematic synthesis of qualitative research. Transplant International, 25(11), 1138-1149. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Nefrologia, 32(1), 1-6. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Current Opinion in Organ Transplantation, 17(4), 362-367. [More Information]
  • Garcia Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Archives of Iranian Medicine, 15(2), 102-106. [More Information]
  • Garcia Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Iranian Journal of Kidney Diseases, 6(2), 81-87. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Nephron Clinical Practice, 120(2), C1 - Refereed Journal articles01-C1 - Refereed Journal articles06. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. American Journal of Nephrology, 35(3), 259-264. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Current Opinion In Nephrology And Hypertension. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Journal of Nephrology, 25(1), 1-6. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Kidney and Blood Pressure Research, 35(5), 299-304. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Transplantation, 93(4), 337-341. [More Information]
  • Tong, A., Chapman, J., Wong, G., Kanellis, J., McCarthy, G., Craig, J. (2012). The Motivations and Experiences of Living Kidney Donors: A Thematic Synthesis. American Journal of Kidney Diseases, 60(1), 15-26. [More Information]
  • Wong, G., Zoungas, S., Lo, S., Chalmers, J., Cass, A., Neal, B., Woodward, M., Perkovic, V., Glasziou, P., Williams, B., Howard, K., Chapman, J., Craig, J. (2012). The risk of cancer in people with diabetes and chronic kidney disease. Nephrology, Dialysis, Transplantation, 27(8), 3337-3344. [More Information]
  • Glotz, D., Chapman, J., Dharnidharka, V., Hanto, D., Castro, M., Hirschc, H., Leblond, V., Mehta, A., Moulin, B., Pagliuca, A., Webster, A., et al (2012). The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders. Transplantation, 94(8), 784-793. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J., Martin, S. (2012). Transplantation: The global role of kidney transplantation. Nature Reviews Nephrology, 8. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). World kidney day 2012: The global role of kidney transplantation. Brunei International Medical Journal, 8(1), 1-9. [More Information]
  • Chapman, J. (2011). Chronic Calcineurin Inhibitor Nephrotoxicity - Lest We Forget. American Journal Of Transplantation, 11(4), 693-697. [More Information]
  • Chapman, J. (2011). Chronic Calcineurin Inhibitor Use Is Nephrotoxic. Clinical Pharmacology and Therapeutics, 90(2), 207-209. [More Information]
  • Holdaas, H., Rostaing, L., Seron, D., Cole, E., Chapman, J., Fellstrom, B., Strom, E., Jardine, A., Midtvedt, K., Machein, U., O'Connell, P., et al (2011). Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study. Transplantation, 92(4), 410-418. [More Information]
  • Ong, A., Blyth, C., Bency, R., Vicaretti, M., Harun, A., Meyer, W., Shingde, M., Gilroy, N., Chapman, J., Chen, S. (2011). Fatal mycotic aneurysms due to scedosporium and pseudallescheria infection. Journal of Clinical Microbiology, 49(5), 2067-2071. [More Information]
  • Dranchenberg, C., Torrealba, J., Nankivell (Nankievell), B., Rangel, E., Bajema, I., Kim, D., Arend, L., Bracamonte, E., Bromberg, J., Bruijin, J., Chapman, J., et al (2011). Guidelines for the Diagnosis of Antibody-Mediated Rejection in Pancreas Allografts-Updated Banff Grading Schema. American Journal Of Transplantation, 11(9), 1792-1802. [More Information]
  • Boo, M., van Walraven, S., Chapman, J., Lindberg, B., Schmidt, A., Shaw, B., Switzer, G., Yang, E., Egeland, T. (2011). Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. Blood, 117(1), 21-25. [More Information]
  • Tong, A., Chapman, J., Wong, G., de Bruijn, J., Craig, J. (2011). Screening and Follow-Up of Living Kidney Donors: A Systematic Review of Clinical Practice Guidelines. Transplantation, 92(9), 962-972. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2011). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Henderson, L., Nankivell (Nankievell), B., Chapman, J. (2011). Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice. American Journal Of Transplantation, 11(8), 1570-1575. [More Information]
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Chapman, J. (2011). The consequences of successful transplantation. The Lancet, 378(9800), 1357-1359. [More Information]
  • Sarwal, M., Benjamin, J., Butte, A., Davis, M., Wood, K., Chapman, J. (2011). Transplantomics and biomarkers in organ transplantation: a report from the first international conference. Transplantation, 91(4), 379-382. [More Information]
  • Chapman, J. (2010). Clinical renal transplantation: where are we now, what are our key challenges? Transplantation Proceedings, 42(9), S3-S6. [More Information]
  • Kuypers, D., Le Meur, Y., Cantarovich, M., Tredger, M., Tett, S., Cattaneo, D., Tonshoff, B., Holt, D., Chapman, J., van Gelder, T. (2010). Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation. Clinical Journal of the American Society of Nephrology, 5(2), 341-358. [More Information]
  • Tilney, N., Chapman, J., Delmonico, F. (2010). Debate on financial incentives is off the mark of national and international realities. Transplantation, 89(7), 906-907. [More Information]
  • van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C., Grulich, A. (2010). Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ, 340(c570), c570-1-c570-6. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database of Systematic Reviews, CD003897(1), 1-146. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin-2 Receptor Antagonists Versus ATG FOR Kidney Transplant Recipients; An Updated Cochrane Systematic Review. Transplantation, 90(Suppl: 22), 22.
  • Kasiske, B., Zeier, M., Chapman, J., Craig, J., Ekberg, H., Garvey, C., Green, M., Jha, V., Josephson, M., et al (2010). KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney International, 77(4), 299. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Vajdic, C., van Leeuwen, M., Turner, J., McDonald, A., Webster, A., McDonald, S., Chapman, J., Kaldor, J., Grulich, A. (2010). No excess risk of follicular lymphoma in kidney transplant and HIV-related immune deficiency. International Journal of Cancer, 127, 2732-2735. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., Wong, G., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Optimizing Serum Creatinine Monitoring For The Rapid Detection Of Complications In The Early Post-Kidney Transplant Period. Transplantation, 90(Suppl 2:977), 977.
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Prediction of Serum Creatinine In The First Month Following Uncomplicated Kidney Transplantation. Transplantation, 90(Suppl 2:876), 876.
  • Chapman, J. (2010). President's Address. The Transplantation Society-Vancouver 2010. Transplantation, 90(12), 1248-1250. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for Renal Cancer in Recipients of Kidney Transplants. Transplantation, 90(Suppl), 391-391.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Chapman, J. (2010). The KDIGO clinical practice guidelines for the care of kidney transplant recipients. Transplantation, 89(6), 644-645. [More Information]
  • Tai, E., Chapman, J. (2010). The KDIGO review of the care of renal transplant recipient. Polskie Archiwum Medycyny Wewnetrznej, 120(6), 237-242. [More Information]
  • Vitalone, M., O'Connell, P., Wavamunno, M., Fung, C., Chapman, J., Nankivell (Nankievell), B. (2010). Transcriptome Changes of Chronic Tubulointerstitial Damage in Early Kidney Transplantation. Transplantation, 89(5), 537-547. [More Information]
  • Webster, A., Supramaniam, R., O’Connell, D., Chapman, J., Craig, J. (2010). Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology, 15(4), 491-501. [More Information]
  • Chapman, J. (2010). Waiting for a liver transplant.. Internal Medicine Journal, 40(9), 609-610. [More Information]
  • Wong, G., Hayen, A., Chapman, J., Webster, A., Wang, J., Mitchell, P., Craig, J. (2009). Association of CKD and Cancer Risk in Older People. Journal of the American Society of Nephrology, 20(6), 1341-1350. [More Information]
  • Campistol, J., Boletis, I., Dantal, J., de Fijter, J., Hertig, A., Neumayer, H., Oyen, O., Pascual, J., Pohanka, E., RUIZ, J., Chapman, J., et al (2009). Chronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitors. Clinical Transplantation, 23(6), 769-777. [More Information]
  • Vajdic, C., van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., Chapman, J., Amin, J., McDonald, S., Grulich, A. (2009). Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients. Cancer Epidemiology, Biomarkers and Prevention, 18(8), 2297-2303. [More Information]
  • Kliem, V., Michel, U., Burg, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Lebranchu, Y., Oppenheimer, F., Pohanka, E., et al (2009). Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clinical Nephrology, 71(4), 423-429. [More Information]
  • van Leeuwen, M., Grulich, A., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood, 114(3), 630-637. [More Information]
  • van Leeuwen, M., Grulich, A., McDonald, S., McCredie, M., Amin, J., Stewart, J., Webster, A., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 561-569. [More Information]
  • Chapman, J. (2009). Not that day .. Medical Journal of Australia, 191, 613-614. [More Information]
  • Wong, G., Webster, A., Chapman, J., Craig, J. (2009). Reported cancer screening practices of nephrologists: results from a national survey. Nephrology, Dialysis, Transplantation, 24(7), 2136-2143. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2009). The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation, 87(7), 1078-1091. [More Information]
  • Stewart, J., Vajdic, C., van Leeuwen, M., Amin, J., Webster, A., Chapman, J., McDonald, S., Grulich, A., McCredie, M. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrology, Dialysis, Transplantation, 24(10), 3225-3231. [More Information]
  • Akima, S., Hawthorne, W., Favaloro, E., Patel, A., Blyth, K., Mudaliar, M., Chapman, J., O'Connell, P. (2009). Tirofiban and Activated Protein C Synergistically Inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from Allogeneic Islet Cells Exposure to Human Blood. American Journal Of Transplantation, 9, 1533-1540. [More Information]
  • Chapman, J., O'Connell, P. (2009). XXII International Congress of The Transplantation Society. Transplantation Proceedings, 41(1), 13. [More Information]
  • BURKE, J., Brault, Y., Kahan, B., Hricik, D., Grinyo, J., Chapman, J., Polinsky, M., Neylan, J. (2008). Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transplant International, 21(5), 434-440. [More Information]
  • Chapman, J. (2008). Addressing the challenges for improving long-term outcomes in renal transplantation. Transplantation Proceedings, 40(10), S2-S4. [More Information]
  • Chapman, J., Nankivell (Nankievell), B., Reinholt, F., Renaudin, K., Revelo, P., Ruiz, P., Torrealba, J., Vazquez-Martul, E., Voska, L., Stratta, R., et al (2008). Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. American Journal Of Transplantation, 8(6), 1237-1249. [More Information]
  • Wong, G., Chapman, J., Craig, J. (2008). Cancer Screening in Renal Transplant Recipients: What Is the Evidence. Clinical Journal of the American Society of Nephrology, 3(Suppl 2), S87-S100. [More Information]
  • Wong, G., Chapman, J. (2008). Cancers after renal transplantation. Transplantation Reviews, 22, 141-149. [More Information]
  • Seron, D., Arns, W., Chapman, J. (2008). Chronic allograft nephropathy-clinical guidance for early detection and early intervention strategies. Nephrology, Dialysis, Transplantation, 23(8), 2467-2473. [More Information]
  • Wong, G., Howard, K., Chapman, J., Craig, J. (2008). Cost-Effectiveness of Breast Cancer Screening in Women on Dialysis. American Journal of Kidney Diseases, 52(5), 916-929. [More Information]
  • Wong, G., Howard, K., Craig, J., Chapman, J. (2008). Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation, 85(4), 532-541. [More Information]
  • Seale, H., Dwyer, D., Chapman, J., MacIntyre, C. (2008). Cytomegalovirus Disease Amongst Renal Transplant Recipients in Australia and New Zealand. Virology: Research and Treatment, 1, 65-73.
  • Vitalone, M., O'Connell, P., Jimenez, E., Yuksel, A., Wavamunno, M., Fung, C., Chapman, J., Nankivell (Nankievell), B. (2008). Epithelial-to-Mesenchymal Transition in Early Transplant Tubulointerstitial Damage. Journal of the American Society of Nephrology, 19(8), 1571-1583. [More Information]
  • Shinozaki, N., Holland, E., Kearney, J., Kurz, J., Chapman, J. (2008). Global Coding System for Human Cells and Tissues for Transplantation. Transplantation, 86(1), 181. [More Information]
  • Buell, J., Daily, P., McBride, M., Chapman, J., Delmonico, F., Buell, J., Daily, P., McBride, M., Delmonico, F. (2008). H. Myron Kaufman (1933-2007) medical director and senior scientist of UNOS: Transplant surgeon and friend. American Journal Of Transplantation, 8(3), 719-720. [More Information]
  • White, S., Chadban, S., Jan, S., Chapman, J., Cass, A. (2008). How can we achieve global equity in provision of renal replacement therapy. Bulletin of the World Health Organization, 86(3), 229-237. [More Information]
  • Wavamunno, M., Chapman, J. (2008). Individualization of immunosuppression: concepts and rationale. Current Opinion in Organ Transplantation, 13(6), 604-608. [More Information]
  • Chapman, J. (2008). Introduction: targets for improving outcomes in renal allografts transplanted during the next ten years. Transplantation, 85(7), S1-S2. [More Information]
  • Webster, A., Wong, G., Craig, J., Chapman, J. (2008). Managing Cancer Risk and Decision Making After Kidney Transplantation. American Journal Of Transplantation, 8(11), 2185-2191. [More Information]
  • Meares, S., Shores, E., Taylor, A., Batchelor, J., Bryant, R., Baguley, I., Chapman, J., Gurka, J., Dawson, K., Capon, L., et al (2008). Mild traumatic brain injury does not predict acute postconcussion syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 79(3), 300-306. [More Information]
  • Chapman, J., Allen, R. (2008). Paired kidney exchange: how far and how wide? Transplantation, 85(5), 673-674. [More Information]
  • Chapman, J. (2008). Should we pay donors to increase the supply of organs for transplantation? No. British Medical Journal, 336(7657), 1343. [More Information]
  • Chapman, J. (2008). The Transplantation Society recognition awards 2008. Transplantation, 86(12), 1653-7. [More Information]
  • Horton, P., Hawthorne, W., Walters, S., Patel, T., Stewart, G., Allen, R., Chapman, J. (2008). Tolerance Induction in a Large-Animal Model Using Total Lymphoid Irradiation and Intrathymic Bone Marrow. Transplantation, 86(12), 1830-1836. [More Information]
  • Chapman, J., Hunsicker, L., Josephson, M., Kasiske, B., Kirste, G., Leichtman, A., Munn, S., Wadstrom, J., Zhang, S., Delmonico, F., et al (2007). A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation, 83(8), S1-22. [More Information]
  • Friend, P., Russ, G., Oberbauer, R., Murgia, M., Tufveson, G., Chapman, J., Blancho, G., Mota, A., Grandaliano, G., et al (2007). Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. Transplant International, 20(9), 754-760. [More Information]
  • Vajdic, C., van Leeuwen, M., McDonald, S., McCredie, M., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2007). Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation. National Cancer Institute. Journal, 99(17), 1340-1342. [More Information]
  • Nankivell (Nankievell), B., Wavamunno, M., Borrows, R., Vitalone, M., Fung, C., Allen, R., Chapman, J., O'Connell, P. (2007). Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology. American Journal Of Transplantation, 7(2), 366-376. [More Information]
  • Chapman, J., Valantine, H., Albanell, J., Arns, W., Campistol, J., Eisen, H., Frigerio, M., Lehmkuhl, H., Marcen, R., Morris, R., Nashan, B., Pascual, J., Pohanka, E., Segovia, J., Zuckermann, A. (2007). Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. Transplantation Proceedings, 39(10), 2937-2950. [More Information]
  • Mengel, M., Chapman, J., Cosio, F., Cavaille-Coll, M., Haller, H., Halloran, P., Kirk, A., Mihatsch, M., Nankivell (Nankievell), B., Racusen, L., et al (2007). Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. American Journal Of Transplantation, 7(3), 512-517. [More Information]
  • Wavamunno, M., O'Connell, P., Vitalone, M., Fung, C., Allen, R., Chapman, J., Nankivell (Nankievell), B. (2007). Transplant Glomerulopathy: Ultrastructural Abnormalities Occur Early in Longitudinal Analysis of Protocol Biopsies. American Journal Of Transplantation, 7(12), 2757-2768. [More Information]
  • Campistol, J., Albanell, J., Arns, W., Boletis, I., Dantal, J., de Fijter, J., Mortensen, S., Neumayer, H., Oyen, O., Pascual, J., Chapman, J., et al (2007). Use of proliferation signal inhibitors in the management of post-transplant malignancies - clinical guidance. Nephrology, Dialysis, Transplantation, 22(Supp1), i36-i41. [More Information]
  • Chadban, S., Campbell, S., Russ, G., Walker, R., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thompson, N., Hutchison, B., et al (2006). A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. Immunology and Cell Biology, 84(3), A6-A6.
  • Vajdic, C., McDonald, S., McCredie, M., van Leeuwen, M., Stewart, J., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2006). Cancer incidence before and after kidney transplantation. JAMA: The Journal of the American Medical Association, 296(23), 2823-2831. [More Information]
  • Nankivell (Nankievell), B., Chapman, J. (2006). Chronic Allograft Nephropathy: Current Concepts and Future Directions. Transplantation, 81(5), 643-654. [More Information]
  • O'Connell, P., Hawthorne, W., Holmes-Walker, D., Nankivell (Nankievell), B., Gunton, J., Patel, A., Walters, S., Pleass, H., Allen, R., Chapman, J. (2006). Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Medical Journal of Australia, 184(5), 221-225. [More Information]
  • Vitalone, M., Kirk, M., Allen, R., Pleass, H., Chapman, J., O'Connell, P., Nankivell (Nankievell), B. (2006). Epithelial-to-mesenchymal transition (EMT) in chronic allograft nephropathy (CAN). 84(3), A2-A2.
  • Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., et al (2006). Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation, 81(2), 202-206.
  • Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Salvadori, M., Tufveson, G. (2006). Follow-up after renal transplantation with organs from donors after cardiac death. Transplant International, 19(9), 715-719. [More Information]
  • Chapman, J. (2006). Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2. [More Information]
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials. 84(3), A3-A3.
  • Chapman, J. (2006). Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients. 84(3), A7-A7.
  • Salvadori, M., Rosati, A., Bertoni, E., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., et al (2006). Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: An insight from MOST, a multinational observational study. Transplantation Proceedings, 38(4), 1010-1013.
  • Chapman, J. (2006). Managing cardiovascular risk in renal transplant recipients: The role of everolimus - Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2.
  • Chapman, J. (2006). Managing cardiovascular risk in renal transplant recipients: The ruole of everolimus - Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation, 81(7), 953-965. [More Information]
  • Wavamunno, M., Vitalone, M., Borrows, R., Fung, C., Allen, R., O'Connell, P., Chapman, J., Nankivell (Nankievell), B. (2006). Mycophenolate mofetil reduces the histological expression of chronic allograft nephropathy. Immunology and Cell Biology, 84(3), A11-A11.
  • Chapman, J., Nankivell (Nankievell), B. (2006). Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrology, Dialysis, Transplantation, 21(8), 2060-2063. [More Information]
  • Chapman, J. (2006). Not All Donors Are Equal. Transplantation, 81(7), 976-977. [More Information]
  • Mathew, T., Chapman, J. (2006). Organ donation: a chance for Australia to do better. Medical Journal of Australia, 185(5), 245-246.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database of Systematic Reviews, 19(2), CD004756-CD004756. [More Information]
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (Issue 2), 1-126. [More Information]
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancers in kidney transplant recipients in Australia and New Zealand. Immunology and Cell Biology, 84(3), A13-A13.
  • Chapman, J. (2006). Scoring arteriolar hyalinosis in renal allograft biopsies: so important and yet so tricky. Nature Clinical Practice Nephrology, 2, 622-623. [More Information]
  • Eris, J., Russ, G., Hutchison, B., Walker, R., Chapman, J., Pussell, B., Mahoney, J., Campbell, S., Brault, Y., Burke, J., et al (2006). Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation. Immunology and Cell Biology, 84(3), A19-A19.
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation, 81(9), 1234-1248. [More Information]
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database of Systematic Reviews, 19(2), CD004290-CD004290. [More Information]
  • Groth, C., Chapman, J. (2006). The global alliance for transplantation. Transplantation Proceedings, 38(2), 356-357. [More Information]
  • Nankivell (Nankievell), B., Chapman, J. (2006). The Significance of Subclinical Rejection and the Value of Protocol Biopsies. American Journal Of Transplantation, 6(9), 2006-2012. [More Information]
  • Robertson, P., Allen, R., O'Connell, P., Pleass, H., Nankivell (Nankievell), B., Waugh, D., Chapman, J. (2006). Transplant beta cell function and the 'lazarus factor'. 84(3), A10-A10.
  • Chapman, J., Allen, R., Nankivell (Nankievell), B., O'Connell, P., Fung, C., Kee, T., Kable, K., Vitalone, M. (2006). Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney Transplants. Transplantation, 82(1), 36-42. [More Information]
  • Allen, R., Lau, H., Nankivell (Nankievell), B., O'Connell, P., Lennox, A., Pussell, B., Chapman, J. (2006). When all the planets are in alignment. 84 (Suppl.)(3), A22-A22.
  • Wong, K., Kable, K., Hawthorne, W., Robertson, P., Chan, K., Nankivell (Nankievell), B., O'Connell, P., Chapman, J., Lau, H., Pleass, H., Allen, R. (2005). A comparison of 2 surgical techniques in pancreas transplantation. Immunology and Cell Biology, 83(4), A23-A24.
  • Verran, D., Sheridan, A., Barnwell, A., Berriman, M., Chapman, J. (2005). Biopsy of potential cadaveric renal allografts at the time of retrieval. Nephrology, 10(4), 414-417. [More Information]
  • Chapman, J., O'Connell, P., Nankivell (Nankievell), B. (2005). Chronic renal allograft dysfunction. Journal of the American Society of Nephrology, 16(10), 3015-3026. [More Information]
  • Chapman, J. (2005). Commentary: harmonizing the regulators. Transplantation, 79(6), 638-638.
  • Chapman, J. (2005). Commentary: harmonizing the regulators. Transplantation, 79(6), 638. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased Kidney Donor Suitability Guidelines. Nephrology, 10(Supplement 4), S116-S132. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased kidney donor suitability guidelines: Non-heart-beating donors. Nephrology, 10(S4), S116-S119. [More Information]
  • Lebranchu, Y., Halimi, J., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Oppenheimer, F., Pohanka, E., Salvadori, M., et al (2005). Delayed graft function: Risk factors, consequences and parameters affecting outcome - Results from MOST, a multinational observational study. Transplantation Proceedings, 37(1), 345-347.
  • OBERBAUER, R., Segoloni, G., Campistol, J., Kreis, H., MOTA, A., Lawen, J., Russ, G., Grinyo, J., Stallone, G., Hartmann, A., Chapman, J., et al (2005). Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant International, 18(1), 22-28.
  • Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Rosati, A., Salvadori, M., et al (2005). Follow-up after renal transplantation with organs from non-heartbeating donors (NHBD). American Journal Of Transplantation, 5(S11), 395-395.
  • O'Connell, P., Hawthorne, W., Simond, D., Chapman, J., Chen, Y., Patel, A., Walters, S., Burgess, J., Weston, L., Stokes, R., Moran, C., Allen, R. (2005). Genetic and Functional evaluation of the level of inbreeding of the Westran pig: a herd with potential for use in xenotransplantation. Xenotransplantation, 12(4), 308-315. [More Information]
  • Salvadori, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., et al (2005). Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: Analysis of the MOST database. Transplantation Proceedings, 37(6), 2464-2466.
  • Chapman, J. (2005). Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney International, 68(99), S108-S112. [More Information]
  • Lee, V., Chapman, J. (2005). Sirolimus: its role in nephrology. Nephrology, 10(6), 606-14. [More Information]
  • Webster, A., Woodroffe, R., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ: British Medical Journal, 331(7520), 1-11. [More Information]
  • Webster, A., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (4), 1-111. [More Information]
  • Groth, C., Chapman, J. (2005). The Global Alliance for Transplantation. Transplantation, 79(9), 994-996. [More Information]
  • Wavamunno, M., Nankivell (Nankievell), B., Chapman, J., Kable, K., Allen, R., Pleass, H., O'Connell, P. (2005). The impact of screening for BK virus in renal allograft recipients. Immunology and Cell Biology, 83(4), A15-A16.
  • Chapman, J., Groth, C., Wood, K. (2005). The needs for a Global Alliance for Transplantation. Clinical Transplants, 2005, 273-279. [More Information]
  • Vitalone, M., Nankivell (Nankievell), B., Kirk, M., Allen, R., Pleass, H., Lau, H., Chapman, J., O'Connell, P. (2005). The use of gene arrays to study the pathogenesis of chronic allograft nephropathy (CAN). Immunology and Cell Biology, 83(4), A26-A26.
  • Tilden, D., Chapman, J., Davey, P., Solly, M., Crowley, S. (2004). A Decision-Analytic Economic Evaluation Of Valaciclovir Prophylaxis For The Prevention Of Cytomegalovirus Infection And Disease In Renal Transplantation. Clinical Transplantation, 18(3), 321-320.
  • Yuan, F., Watson, N., Sullivan, J., Biffin, S., Moses, J., Geczy, A., Chapman, J. (2004). Association Of Fc Gamma Receptor Iia Polymorphisms With Acute Renal-Allograft Rejection. Transplantation, 78(5), 766-769.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Chapman, J., Allen, R. (2004). Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment By Protocol Histology. Transplantation, 78(4), 557-565.
  • Chapman, J. (2004). Compliance: The Patient, The Doctor, And The Medication? Transplantation, 77(5), 782-786.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Chapman, J., Allen, R. (2004). Delta Analysis Of Posttransplantation Tubulointerstitial Damage. Transplantation, 78(3), 434-441.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2004). Evolution And Pathophysiology Of Renal-Transplant Glomerulosclerosis. Transplantation, 78(3), 461-468.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Kidney Transplant Recipients. Cochrane Database of Systematic Reviews, Jan 2004(1), CD003897.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Renal Transplant Recipients: A Meta-Analysis Of Randomized Trials. Transplantation, 77(2), 166-176.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2004). Natural History, Risk Factors, And Impact Of Subclinical Rejection In Kidney Transplantation. Transplantation, 78(2), 242-249.
  • Nankivell (Nankievell), B., Chapman, J., Bonovas, G., Gruenewald, S. (2004). Oral Cyclosporine But Not Tacrolimus Reduces Renal Transplant Blood Flow. Transplantation, 77(9), 1457-1459.
  • Chapman, J., Russ, G. (2003). Geographic variance in access to renal transplantation in Australia. Transplantation, 76(9), 1403-1406.
  • OBERBAUER, R., Kreis, H., JOHNSON, R., MOTA, A., CLAESSON, K., RUIZ, J., WILCZEK, H., JAMIESON, N., HENRIQUES, A., PACZEK, L., Chapman, J., et al (2003). Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplacnt recipients: 2-year results fo the rapamune maintenacne regimen study. Transplantation, 76(2), 364-370.
  • Chapman, J. (2003). Optimizing the long-term outcome of renal transplants: opportunities created by Sirolimus. Transplantation Proceedings, 35(3 supplement 1), 67S-72S.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2003). The natural history of chronic allograft nephropathy. New England Journal of Medicine, 349(24), 2326-2333.
  • Nankivell (Nankievell), B., Chapman, J., Gruenewald, S. (2002). Detection of chronic allograft nephropathy by quantitative doppler imaging. Transplantation, 74, 90-96.
  • Chapman, J. (2001). A different view of sensitization after renal transplant rejection? Transplantation, 71, 825-826.
  • Neal, B., Chapman, J., Chalmers, J., MacMahon, S., Girgis, S., Patel, A. (2001). Blood pressure and the vascular complications of diabetes. Medicographia, 23(3), 214-219.
  • Nankivell (Nankievell), B., Chapman, J., Gruenewald, S., Cohn,, D., Timothy, S., Evans,, S. (2001). Diagnosis of kidney transplant obstruction using Mag3 diuretic renography. Clinical Transplantation, 15, 11-18.
  • Nankivell (Nankievell), B., Fenton Lee, C., Allen, R., O'Connell, P., Chapman, J., Kuypers, D., Cheung,, E. (2001). Effect of Histological damage on long-term kidney transplant outcome. Transplantation, 71, 515-523.
  • Verran, D., deLeon, C., Chui,, A., Chapman, J. (2001). Factors in older cadaveric organ donors impacting on renal allograft outcome. Clinical Transplantation, 15, 1-5.
  • Nankivell (Nankievell), B., Fenton Lee, C., Allen, R., O'Connell, P., Chapman, J., Kuypers, D. (2001). Histological injury and renal transplant outcome: the cumulative damage hypothesis. Transplantation Proceedings, 33, 1149-1150.
  • Allen, R., Nankivell (Nankievell), B., Hawthorne, W., O'Connell, P., Chapman, J. (2001). Pancreas and islet transplantation: an unfinished journey. Transplantation Proceedings, 33, 3485-3488.
  • Chapman, J., Sheil, A., Disney, A. (2001). Recurrence of cancer after renal transplantation. Transplantation Proceedings, 33(1-2), 1830-1831.
  • Chapman, J. (2001). Sirolimus: searching for its niche or a therapy that has come of age? Transplantation, 72, 774-775.
  • Chapman, J., Robertson, P., Allen, R. (2001). Why do pancreas transplants thrombose? Transplantation, 72, 182-183.
  • Hawthorne, W., Cachia, A., Walters, S., Patel, A., Clarke, J., O'Connell, P., Chapman, J., Allen, R. (2000). A large-animal model to evaluate the clinical potential of fetal pig pancreas fragment transplantation. Cell Transplantation, 9, 867-875.
  • Horton, P., Hawthorne, W., Walters, S., Patel, A., O'Connell, P., Chapman, J., Allen, R. (2000). Induction of allogenic islet tolerance in a large-animal model. Cell Transplantation, 9, 877-887.
  • Wallman, L., Stewart, G., Chapman, J., O'Connell, P., Fulcher, D. (2000). Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases. Internal Medicine Journal, 30, 712-715.
  • Pai, R., Mitchell, P., Chow, C., Chapman, J., O'Connell, P., Allen, R., Nankivell (Nankievell), B. (2000). Posttransplant cataract: lessons from kidney-pancreas transplantation. Transplantation, 69, 1108-1114.
  • Nankivell (Nankievell), B., Lau, S., Chapman, J., O'Connell, P., Fletcher, J., Allen, R. (2000). Progression of macrovascular disease after transplantation. Transplantation, 69, 574-581.

Conferences

  • Batabyal, P., Chapman, J., Wong, G., Craig, J., Tong, A. (2012). Clinical Practice Guidelines For Kidney Transplantation: A Systematic Review. 24th International Congress of The Transplantation Society, The International Congress Centre Berlin (ICC Berlin), Berlin, Germany.
  • Batabyal, P., Tong, A., Chapman, J., Wong, G., Craig, J. (2012). Clinical practice guidelines on waitlisting for kidney transplantation: a systematic review. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). Desperation, Despair and Debasement: Thematic Synthesis of Qualitative Research on the Experiences of Commercial Kidney Donors. 24th International Congress of The Transplantation Society, The International Congress Centre Berlin (ICC Berlin), Berlin, Germany.
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). Desperation, Despair, and Debasement: Thematic Synthesis Of Qualitative Research On The Experiences Of Commercial Kidney Donors. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Didsbury, M., Craig, J., Tong, A., Chapman, J., Kable, K., Wong, G. (2012). Exercise training in solid organ transplant recipients - A systematic Review. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Tong, A., Chapman, J., Wong, G., Kanellis, J., McCarthy, G., Craig, J. (2012). The Motivations and Experiences of Living Kidney Donors: A Thematic Synthesis. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Chapman, J., D'Errico-Grigioni, A., Matesanz, R., Dominguez-Gil, B., Marazuela, R., Breindenbach, T., Fischer-Fröhlich, C., Kirste, G., Mahíllo, B., Moench, K., Webster, A. (2011). The Transmission of Malignancies. NOTIFY: Exploring Vigilance Notification for Organs, Tissues and Cells, Bologna, Italy: Editrice Compositori Srl.
  • Goddard, K., Pleass, H., Cross, N., O'Connell, P., Chapman, J., Nankivell (Nankievell), B., Allen, R. (2006). A twist of fate or fated to twist?
  • Webster, A., Lee, V., Powell, J., Chapman, J., Craig, J. (2004). (O78) Tor-Inhibitors (sirolimus and everolimus) for primary immunosuppression of renal transplant recipients: A meta-analysis randomized trials. IPNA meeting, 13th Congress.
  • Webster, A., Byrne, B., McDonald, S., Craig, J., Chapman, J. (2004). (O91) Incidence, risk and predictors of cancer after renal transplantation: An analysis of ANZDATA. IPNA meeting, 13th Congress.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2002). IL2 receptor antagonists for renal transplant recipients: a systematic review of randomised controlled trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.

2014

  • Lim, W., Turner, R., Chapman, J., Ma, M., Webster, A., Craig, J., Wong, G. (2014). Acute Rejection, T-Cell-Depleting Antibodies, and Cancer After Transplantation. Transplantation, 97(8), 817-925. [More Information]
  • Huang, J., Zheng, S., Liu, Y., Wang, H., Chapman, J., O'Connell, P., Millis, M., Fung, J., Delmonico, F. (2014). China organ donation and transplantation update: the Hangzhou Resolution. Hepatobiliary & Pancreatic Diseases International, 13(2), 122-124. [More Information]
  • Chapman, J., Lynch, S. (2014). Donor-transmitted, donor-derived, and de novo cancer after liver transplant. Experimental and Clinical Transplantation, 12(Suppl 1), 50-54. [More Information]
  • Chung, R., Howard, K., Craig, J., Chapman, J., Turner, R., Wong, G. (2014). Economic evaluations in kidney transplantation: frequency, characteristics, and quality-a systematic review. Transplantation, 97(10), 1027-1033. [More Information]
  • Ralph, A., Chapman, J., Gillis, J., Craig, J., Butow, P., Howard, K., Irving, M., Sutanto, B., Tong, A. (2014). Family perspectives on deceased organ donation: thematic synthesis of qualitative studies. American Journal of Transplantation, 14(4), 923-935. [More Information]
  • Nguyen, H., Wong, G., Howard, K., Claas, F., Craig, J., Fidler, S., D'Orsogna, L., Chapman, J., Irish, A., Ferrari, P., et al (2014). Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients. Transplantation, 97(7), 769-774. [More Information]
  • Buell, J., Shores, N., Gross, T., Chapman, J., Webster, A. (2014). Post-Transplant Lymphoproliferative Disorder. In James Neuberger, James Ferguson and Philip N. Newsome (Eds.), Liver Transplantation: Clinical Assessment and Management, (pp. 325-336). Oxford: John Wiley & Sons.
  • Wong, G., Lim, W., Chapman, J. (2014). Questioning the Myth: Benefits of Renin-Angiotensin System Blockade in Kidney Transplant Recipients. Transplantation, 97(3), 271-272. [More Information]

2013

  • Chapman, J., Rangan, G. (2013). Are Nonesterified Fatty Acids Protective in Chronic Allograft Nephropathy? Transplantation, 95(11), 1313-1314. [More Information]
  • Carroll, R., Chapman, J. (2013). Can the risk of skin cancer after transplantation be reduced by mTOR Inhibitors? American Journal of Kidney Diseases, 61(5), 698-700. [More Information]
  • Chapman, J., Webster, A., Wong, G. (2013). Cancer in the Transplant Recipient. Cold Spring Harbor Perspectives in Medicine, 3(7), 1-15. [More Information]
  • Chapman, J. (2013). China and the organ trade. Medical Journal of Australia, 199(11), 728. [More Information]
  • Tait, B., Susal, C., Gebel, H., Nickerson, P., Zachary, A., Claas, F., Reed, E., Bray, R., Campbell, P., Chapman, J., Webster, A., et al (2013). Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation, 95(1), 19-47. [More Information]
  • Xiao, D., Craig, J., Chapman, J., Dominguez-Gil, B., Tong, A., Wong, G. (2013). Donor Cancer Transmission in Kidney Transplantation: A Systematic Review. American Journal of Transplantation, 13(10), 2645-2652. [More Information]
  • Chapman, J. (2013). Editorial. Transplantation Reviews, 27(2), 37-37. [More Information]
  • Chadban, S., Eris, J., Russ, G., Campbell, S., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thomson, N., Hutchison, B., et al (2013). Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients. Nephrology, 18(1), 63-70. [More Information]
  • Sparke, C., Moon, L., Green, F., Mathew, T., Cass, A., Chadban, S., Chapman, J., Hoy, W., McDonald, S. (2013). Estimating the Total Incidence of Kidney Failure in Australia Including Individuals Who Are Not Treated by Dialysis or Transplantation. American Journal of Kidney Diseases, 61(3), 413-419. [More Information]
  • Didsbury, M., McGee, R., Tong, A., Craig, J., Chapman, J., Chadban, S., Wong, G. (2013). Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Transplantation, 95(5), 679-687. [More Information]
  • Wong, G., Li, M., Howard, K., Hua, D., Chapman, J., Bourke, M., Turner, R., Tong, A., Craig, J. (2013). Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrology, Dialysis, Transplantation, 28(4), 917-926. [More Information]
  • Essue, B., Wong, G., Chapman, J., Li, Q., Jan, S. (2013). How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrology, 14(1), 1-9. [More Information]
  • Tong, A., Chapman, J., Wong, G., Craig, J. (2013). Living Kidney Donor Assessment: Challenges, Uncertainties and Controversies Among Transplant Nephrologists and Surgeons. American Journal Of Transplantation, 13(11), 2912-2923. [More Information]
  • Garcia, M., Chapman, J., Shaw, P., Gottlieb, D., Ralph, A., Craig, J., Tong, A. (2013). Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies. Biology of Blood and Marrow Transplantation, 19(7), 1046-1058. [More Information]
  • Ho, E., Wong, G., Craig, J., Chapman, J. (2013). Once-Daily Extended-Release Versus Twice-Daily Standard-Release Tacrolimus in Kidney Transplant Recipients: A Systematic Review. Transplantation, 95(9), 1120-1128. [More Information]
  • Danovitch, G., Chapman, J., Capron, A., Levin, A., Abbud-Filho, M., Al Mousawi, M., Bennett, W., Budiani-Saberi, D., Couser, W., Dittmer, I., et al (2013). Organ Trafficking and Transplant Tourism: The Role of Global Professional Ethical Standards - The 2008 Declaration of Istanbul. Transplantation, 95(11), 1306-1312. [More Information]
  • Chapman, J., Marriott, D., Chen, S., Macdonald, P. (2013). Post-transplant pneumocystis jirovecii pneumonia-a re-emerged public health problem? Kidney International, 84(2), 240-243. [More Information]
  • Tong, A., Chapman, J., Wong, G., Josephson, M., Craig, J. (2013). Public Awareness and Attitudes to Living Organ Donation: Systematic Review and Integrative Synthesis. Transplantation, 96(5), 429-437. [More Information]
  • Tong, A., Chapman, J., Israni, A., Gordon, E., Craig, J. (2013). Qualitative Research in Organ Transplantation: Recent Contributions to Clinical Care and Policy. American Journal of Transplantation, 13(6), 1390-1399. [More Information]
  • Mohandas, J., Kumar, A., Ranganathan, D., Healy, H., Huang, Y., O’Loughlin, B., Chapman, J., John, G. (2013). Splenunculus Masquerading as a Neuroendocrine Tumor of the Pancreatic Allograft in a Kidney Pancreas Recipient. Transplantation, 96(8), e59-e62. [More Information]
  • Singhai, P., Chapman, J. (2013). Tacrolimus: A Clinician's Perspective on What is Important. In Dimitrios Raptis, Manousos-Georgios Pramateftakis (Eds.), Tacrolimus: Effectiveness, Safety and Drug Interactions, (pp. 41-71). New York: Nova Science Publishers.
  • Myint, T., Turner, R., Craig, J., Cross, N., Kable, K., Nankivell, B., Chapman, J., Webster, A., O'Connell, P., Dwyer, D., Jeoffreys, N., Wong, G., et al (2013). Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients. Clinical Transplantation, 27(5), 571-579. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2013). The global role of kidney transplantation. Nephrology, Dialysis, Transplantation, 28(8), e1-e5. [More Information]
  • Wong, G., Turner, R., Chapman, J., Howell, M., Lim, W., Webster, A., Craig, J. (2013). Time on Dialysis and Cancer Risk After Kidney Transplantation. Transplantation, 95(1), 114-121. [More Information]
  • Gordon, S., Nivison-Smith, I., Szer, J., Chapman, J. (2013). Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective. Internal Medicine Journal, 43(11), 1183-1190. [More Information]

2012

  • Chapman, J. (2012). Balancing sensitivity and specificity - unfolding crossmatch biology in renal transplantation*. Transplant International, 25(11), 1129-1130. [More Information]
  • Batabyal, P., Chapman, J., Wong, G., Craig, J., Tong, A. (2012). Clinical Practice Guidelines For Kidney Transplantation: A Systematic Review. 24th International Congress of The Transplantation Society, The International Congress Centre Berlin (ICC Berlin), Berlin, Germany.
  • Batabyal, P., Chapman, J., Wong, G., Craig, J., Tong, A. (2012). Clinical Practice Guidelines on Wait-Listing for Kidney Transplantation: Consistent and Equitable? Transplantation, 94(7), 703-713. [More Information]
  • Batabyal, P., Tong, A., Chapman, J., Wong, G., Craig, J. (2012). Clinical practice guidelines on waitlisting for kidney transplantation: a systematic review. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Hua, D., Howard, K., Craig, J., Chapman, J., Wong, G. (2012). Cost-Effectiveness of Cidofovir Treatment of Polyomavirus Nephropathy in Kidney Transplant Recipients. Transplantation, 93(2), 188-194. [More Information]
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). Desperation, Despair and Debasement: Thematic Synthesis of Qualitative Research on the Experiences of Commercial Kidney Donors. 24th International Congress of The Transplantation Society, The International Congress Centre Berlin (ICC Berlin), Berlin, Germany.
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). Desperation, Despair, and Debasement: Thematic Synthesis Of Qualitative Research On The Experiences Of Commercial Kidney Donors. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Chapman, J., Nalesnik, M. (2012). Despite the Best Intentions Cancer Is Transmissible by Transplantation. Transplantation, 94(12), 1185-1186. [More Information]
  • Chapman, J. (2012). Do protocol transplant biopsies improve kidney transplant outcomes? Current Opinion In Nephrology And Hypertension, 21(6), 580-586. [More Information]
  • Thwaites, S., Gurung, B., Yao, J., Kable, K., Robertson, P., Ryan, B., Lam, V., Pleass, H., Chapman, J., Hawthorne, W., Allen, R. (2012). Excellent Outcomes of Simultaneous Pancreas Kidney Transplantation in Patients From Rural and Urban Australia: A National Service Experience. Transplantation, 94(12), 1230-1235. [More Information]
  • Didsbury, M., Craig, J., Tong, A., Chapman, J., Kable, K., Wong, G. (2012). Exercise training in solid organ transplant recipients - A systematic Review. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). Global role of kidney transplantation. Hong Kong Journal of Nephrology. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Cowley, M., Weinberg, A., Zammit, N., Walters, S., Hawthorne, W., Loudovaris, T., Thomas, H., Kay, T., Gunton, J., Alexander, S., O'Connell, P., et al (2012). Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplantation, 21(9), 2063-2078. [More Information]
  • Rudge, C., Matesanz, R., Delmonico, F., Chapman, J. (2012). International practices of organ donation. British Journal of Anaesthesia, 108(Suppl 1), i48-i55. [More Information]
  • Ezzatzadegan, S., Chen, S., Chapman, J. (2012). Invasive Fungal Infections after Renal Transplantation. International Journal of Organ Transplantation Medicine, 3(1), 18-25.
  • Williams, N., Tong, A., Howard, K., Chapman, J., Craig, J., Wong, G. (2012). Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer. Nephrology, 17(3), 300-306. [More Information]
  • Wong, G., Chapman, J., Craig, J., Chapman, J. (2012). mTOR inhibitors: a myth, a cure for cancer or something in between? American Journal of Transplantation, 12(5), 1075-1076. [More Information]
  • Clayton, P., McDonald, S., Chapman, J., Chadban, S. (2012). Mycophenolate Versus Azathioprine for Kidney Transplantation: A 15-Year Follow-Up of a Randomized Trial. Transplantation, 94(2), 152-158. [More Information]
  • Chapman, J., Alexander, S. (2012). The Candle Illuminating the Pathway to Tolerance? American Journal of Kidney Diseases, 60(4), 521-523. [More Information]
  • Tong, A., Chapman, J., Wong, G., Cross, N., Batabyal, P., Craig, J. (2012). The experiences of commercial kidney donors: thematic synthesis of qualitative research. Transplant International, 25(11), 1138-1149. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Nefrologia, 32(1), 1-6. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Current Opinion in Organ Transplantation, 17(4), 362-367. [More Information]
  • Garcia Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Archives of Iranian Medicine, 15(2), 102-106. [More Information]
  • Garcia Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Iranian Journal of Kidney Diseases, 6(2), 81-87. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Nephron Clinical Practice, 120(2), C1 - Refereed Journal articles01-C1 - Refereed Journal articles06. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. American Journal of Nephrology, 35(3), 259-264. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Current Opinion In Nephrology And Hypertension. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Journal of Nephrology, 25(1), 1-6. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Kidney and Blood Pressure Research, 35(5), 299-304. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J. (2012). The global role of kidney transplantation. Transplantation, 93(4), 337-341. [More Information]
  • Tong, A., Chapman, J., Wong, G., Kanellis, J., McCarthy, G., Craig, J. (2012). The Motivations and Experiences of Living Kidney Donors: A Thematic Synthesis. American Journal of Kidney Diseases, 60(1), 15-26. [More Information]
  • Tong, A., Chapman, J., Wong, G., Kanellis, J., McCarthy, G., Craig, J. (2012). The Motivations and Experiences of Living Kidney Donors: A Thematic Synthesis. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Wong, G., Zoungas, S., Lo, S., Chalmers, J., Cass, A., Neal, B., Woodward, M., Perkovic, V., Glasziou, P., Williams, B., Howard, K., Chapman, J., Craig, J. (2012). The risk of cancer in people with diabetes and chronic kidney disease. Nephrology, Dialysis, Transplantation, 27(8), 3337-3344. [More Information]
  • Glotz, D., Chapman, J., Dharnidharka, V., Hanto, D., Castro, M., Hirschc, H., Leblond, V., Mehta, A., Moulin, B., Pagliuca, A., Webster, A., et al (2012). The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders. Transplantation, 94(8), 784-793. [More Information]
  • Garcia-Garcia, G., Harden, P., Chapman, J., Martin, S. (2012). Transplantation: The global role of kidney transplantation. Nature Reviews Nephrology, 8. [More Information]
  • Garcia, G., Harden, P., Chapman, J. (2012). World kidney day 2012: The global role of kidney transplantation. Brunei International Medical Journal, 8(1), 1-9. [More Information]

2011

  • Chapman, J. (2011). Chronic Calcineurin Inhibitor Nephrotoxicity - Lest We Forget. American Journal Of Transplantation, 11(4), 693-697. [More Information]
  • Chapman, J. (2011). Chronic Calcineurin Inhibitor Use Is Nephrotoxic. Clinical Pharmacology and Therapeutics, 90(2), 207-209. [More Information]
  • Holdaas, H., Rostaing, L., Seron, D., Cole, E., Chapman, J., Fellstrom, B., Strom, E., Jardine, A., Midtvedt, K., Machein, U., O'Connell, P., et al (2011). Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study. Transplantation, 92(4), 410-418. [More Information]
  • Ong, A., Blyth, C., Bency, R., Vicaretti, M., Harun, A., Meyer, W., Shingde, M., Gilroy, N., Chapman, J., Chen, S. (2011). Fatal mycotic aneurysms due to scedosporium and pseudallescheria infection. Journal of Clinical Microbiology, 49(5), 2067-2071. [More Information]
  • Dranchenberg, C., Torrealba, J., Nankivell (Nankievell), B., Rangel, E., Bajema, I., Kim, D., Arend, L., Bracamonte, E., Bromberg, J., Bruijin, J., Chapman, J., et al (2011). Guidelines for the Diagnosis of Antibody-Mediated Rejection in Pancreas Allografts-Updated Banff Grading Schema. American Journal Of Transplantation, 11(9), 1792-1802. [More Information]
  • Chapman, J., D'Errico-Grigioni, A., Matesanz, R. (2011), NOTIFY: Exploring Vigilance Notification for Organs, Tissues and Cells | The Transmission of Malignancies (p. 79 - 98). , , , 79-97.
  • Boo, M., van Walraven, S., Chapman, J., Lindberg, B., Schmidt, A., Shaw, B., Switzer, G., Yang, E., Egeland, T. (2011). Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. Blood, 117(1), 21-25. [More Information]
  • Tong, A., Chapman, J., Wong, G., de Bruijn, J., Craig, J. (2011). Screening and Follow-Up of Living Kidney Donors: A Systematic Review of Clinical Practice Guidelines. Transplantation, 92(9), 962-972. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2011). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Henderson, L., Nankivell (Nankievell), B., Chapman, J. (2011). Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice. American Journal Of Transplantation, 11(8), 1570-1575. [More Information]
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Chapman, J. (2011). The consequences of successful transplantation. The Lancet, 378(9800), 1357-1359. [More Information]
  • Chapman, J., D'Errico-Grigioni, A., Matesanz, R., Dominguez-Gil, B., Marazuela, R., Breindenbach, T., Fischer-Fröhlich, C., Kirste, G., Mahíllo, B., Moench, K., Webster, A. (2011). The Transmission of Malignancies. NOTIFY: Exploring Vigilance Notification for Organs, Tissues and Cells, Bologna, Italy: Editrice Compositori Srl.
  • Sarwal, M., Benjamin, J., Butte, A., Davis, M., Wood, K., Chapman, J. (2011). Transplantomics and biomarkers in organ transplantation: a report from the first international conference. Transplantation, 91(4), 379-382. [More Information]

2010

  • Chapman, J. (2010). Clinical renal transplantation: where are we now, what are our key challenges? Transplantation Proceedings, 42(9), S3-S6. [More Information]
  • Kuypers, D., Le Meur, Y., Cantarovich, M., Tredger, M., Tett, S., Cattaneo, D., Tonshoff, B., Holt, D., Chapman, J., van Gelder, T. (2010). Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation. Clinical Journal of the American Society of Nephrology, 5(2), 341-358. [More Information]
  • Tilney, N., Chapman, J., Delmonico, F. (2010). Debate on financial incentives is off the mark of national and international realities. Transplantation, 89(7), 906-907. [More Information]
  • van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C., Grulich, A. (2010). Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ, 340(c570), c570-1-c570-6. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database of Systematic Reviews, CD003897(1), 1-146. [More Information]
  • Webster, A., Ruster, L., McGee, R., Matheson, S., Higgins, G., Willis, N., Chapman, J., Craig, J. (2010). Interleukin-2 Receptor Antagonists Versus ATG FOR Kidney Transplant Recipients; An Updated Cochrane Systematic Review. Transplantation, 90(Suppl: 22), 22.
  • Kasiske, B., Zeier, M., Chapman, J., Craig, J., Ekberg, H., Garvey, C., Green, M., Jha, V., Josephson, M., et al (2010). KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney International, 77(4), 299. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Vajdic, C., van Leeuwen, M., Turner, J., McDonald, A., Webster, A., McDonald, S., Chapman, J., Kaldor, J., Grulich, A. (2010). No excess risk of follicular lymphoma in kidney transplant and HIV-related immune deficiency. International Journal of Cancer, 127, 2732-2735. [More Information]
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., Wong, G., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Optimizing Serum Creatinine Monitoring For The Rapid Detection Of Complications In The Early Post-Kidney Transplant Period. Transplantation, 90(Suppl 2:977), 977.
  • Cross, N., Macaskill, P., Hayen, A., Webster, A., O'Connell, P., Chapman, J., Nankivell, B., Craig, J. (2010). Prediction of Serum Creatinine In The First Month Following Uncomplicated Kidney Transplantation. Transplantation, 90(Suppl 2:876), 876.
  • Chapman, J. (2010). President's Address. The Transplantation Society-Vancouver 2010. Transplantation, 90(12), 1248-1250. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for renal cancer in recipients of kidney transplants. Nephrology, Dialysis, Transplantation, 26(5), 1729-1739. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2010). Screening for Renal Cancer in Recipients of Kidney Transplants. Transplantation, 90(Suppl), 391-391.
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Chapman, J. (2010). The KDIGO clinical practice guidelines for the care of kidney transplant recipients. Transplantation, 89(6), 644-645. [More Information]
  • Tai, E., Chapman, J. (2010). The KDIGO review of the care of renal transplant recipient. Polskie Archiwum Medycyny Wewnetrznej, 120(6), 237-242. [More Information]
  • Vitalone, M., O'Connell, P., Wavamunno, M., Fung, C., Chapman, J., Nankivell (Nankievell), B. (2010). Transcriptome Changes of Chronic Tubulointerstitial Damage in Early Kidney Transplantation. Transplantation, 89(5), 537-547. [More Information]
  • Webster, A., Supramaniam, R., O’Connell, D., Chapman, J., Craig, J. (2010). Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology, 15(4), 491-501. [More Information]
  • Chapman, J. (2010). Waiting for a liver transplant.. Internal Medicine Journal, 40(9), 609-610. [More Information]

2009

  • Wong, G., Hayen, A., Chapman, J., Webster, A., Wang, J., Mitchell, P., Craig, J. (2009). Association of CKD and Cancer Risk in Older People. Journal of the American Society of Nephrology, 20(6), 1341-1350. [More Information]
  • Campistol, J., Boletis, I., Dantal, J., de Fijter, J., Hertig, A., Neumayer, H., Oyen, O., Pascual, J., Pohanka, E., RUIZ, J., Chapman, J., et al (2009). Chronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitors. Clinical Transplantation, 23(6), 769-777. [More Information]
  • Vajdic, C., van Leeuwen, M., Webster, A., McCredie, M., Stewart, J., Chapman, J., Amin, J., McDonald, S., Grulich, A. (2009). Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients. Cancer Epidemiology, Biomarkers and Prevention, 18(8), 2297-2303. [More Information]
  • Kliem, V., Michel, U., Burg, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Lebranchu, Y., Oppenheimer, F., Pohanka, E., et al (2009). Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clinical Nephrology, 71(4), 423-429. [More Information]
  • van Leeuwen, M., Grulich, A., Webster, A., McCredie, M., Stewart, J., McDonald, S., Amin, J., Kaldor, J., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood, 114(3), 630-637. [More Information]
  • van Leeuwen, M., Grulich, A., McDonald, S., McCredie, M., Amin, J., Stewart, J., Webster, A., Chapman, J., Vajdic, C. (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 561-569. [More Information]
  • Chapman, J. (2009). Not that day .. Medical Journal of Australia, 191, 613-614. [More Information]
  • Wong, G., Webster, A., Chapman, J., Craig, J. (2009). Reported cancer screening practices of nephrologists: results from a national survey. Nephrology, Dialysis, Transplantation, 24(7), 2136-2143. [More Information]
  • Wong, G., Howard, K., Webster, A., Chapman, J., Craig, J. (2009). The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation, 87(7), 1078-1091. [More Information]
  • Stewart, J., Vajdic, C., van Leeuwen, M., Amin, J., Webster, A., Chapman, J., McDonald, S., Grulich, A., McCredie, M. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrology, Dialysis, Transplantation, 24(10), 3225-3231. [More Information]
  • Akima, S., Hawthorne, W., Favaloro, E., Patel, A., Blyth, K., Mudaliar, M., Chapman, J., O'Connell, P. (2009). Tirofiban and Activated Protein C Synergistically Inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from Allogeneic Islet Cells Exposure to Human Blood. American Journal Of Transplantation, 9, 1533-1540. [More Information]
  • Chapman, J., O'Connell, P. (2009). XXII International Congress of The Transplantation Society. Transplantation Proceedings, 41(1), 13. [More Information]

2008

  • BURKE, J., Brault, Y., Kahan, B., Hricik, D., Grinyo, J., Chapman, J., Polinsky, M., Neylan, J. (2008). Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transplant International, 21(5), 434-440. [More Information]
  • Chapman, J. (2008). Addressing the challenges for improving long-term outcomes in renal transplantation. Transplantation Proceedings, 40(10), S2-S4. [More Information]
  • Chapman, J., Nankivell (Nankievell), B., Reinholt, F., Renaudin, K., Revelo, P., Ruiz, P., Torrealba, J., Vazquez-Martul, E., Voska, L., Stratta, R., et al (2008). Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. American Journal Of Transplantation, 8(6), 1237-1249. [More Information]
  • Wong, G., Chapman, J., Craig, J. (2008). Cancer Screening in Renal Transplant Recipients: What Is the Evidence. Clinical Journal of the American Society of Nephrology, 3(Suppl 2), S87-S100. [More Information]
  • Wong, G., Chapman, J. (2008). Cancers after renal transplantation. Transplantation Reviews, 22, 141-149. [More Information]
  • Seron, D., Arns, W., Chapman, J. (2008). Chronic allograft nephropathy-clinical guidance for early detection and early intervention strategies. Nephrology, Dialysis, Transplantation, 23(8), 2467-2473. [More Information]
  • Wong, G., Howard, K., Chapman, J., Craig, J. (2008). Cost-Effectiveness of Breast Cancer Screening in Women on Dialysis. American Journal of Kidney Diseases, 52(5), 916-929. [More Information]
  • Wong, G., Howard, K., Craig, J., Chapman, J. (2008). Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation, 85(4), 532-541. [More Information]
  • Seale, H., Dwyer, D., Chapman, J., MacIntyre, C. (2008). Cytomegalovirus Disease Amongst Renal Transplant Recipients in Australia and New Zealand. Virology: Research and Treatment, 1, 65-73.
  • Vitalone, M., O'Connell, P., Jimenez, E., Yuksel, A., Wavamunno, M., Fung, C., Chapman, J., Nankivell (Nankievell), B. (2008). Epithelial-to-Mesenchymal Transition in Early Transplant Tubulointerstitial Damage. Journal of the American Society of Nephrology, 19(8), 1571-1583. [More Information]
  • Shinozaki, N., Holland, E., Kearney, J., Kurz, J., Chapman, J. (2008). Global Coding System for Human Cells and Tissues for Transplantation. Transplantation, 86(1), 181. [More Information]
  • Buell, J., Daily, P., McBride, M., Chapman, J., Delmonico, F., Buell, J., Daily, P., McBride, M., Delmonico, F. (2008). H. Myron Kaufman (1933-2007) medical director and senior scientist of UNOS: Transplant surgeon and friend. American Journal Of Transplantation, 8(3), 719-720. [More Information]
  • White, S., Chadban, S., Jan, S., Chapman, J., Cass, A. (2008). How can we achieve global equity in provision of renal replacement therapy. Bulletin of the World Health Organization, 86(3), 229-237. [More Information]
  • Wavamunno, M., Chapman, J. (2008). Individualization of immunosuppression: concepts and rationale. Current Opinion in Organ Transplantation, 13(6), 604-608. [More Information]
  • Chapman, J. (2008). Introduction: targets for improving outcomes in renal allografts transplanted during the next ten years. Transplantation, 85(7), S1-S2. [More Information]
  • Webster, A., Wong, G., Craig, J., Chapman, J. (2008). Managing Cancer Risk and Decision Making After Kidney Transplantation. American Journal Of Transplantation, 8(11), 2185-2191. [More Information]
  • Meares, S., Shores, E., Taylor, A., Batchelor, J., Bryant, R., Baguley, I., Chapman, J., Gurka, J., Dawson, K., Capon, L., et al (2008). Mild traumatic brain injury does not predict acute postconcussion syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 79(3), 300-306. [More Information]
  • Chapman, J., Allen, R. (2008). Paired kidney exchange: how far and how wide? Transplantation, 85(5), 673-674. [More Information]
  • Chapman, J. (2008). Should we pay donors to increase the supply of organs for transplantation? No. British Medical Journal, 336(7657), 1343. [More Information]
  • Chapman, J. (2008). The Transplantation Society recognition awards 2008. Transplantation, 86(12), 1653-7. [More Information]
  • Horton, P., Hawthorne, W., Walters, S., Patel, T., Stewart, G., Allen, R., Chapman, J. (2008). Tolerance Induction in a Large-Animal Model Using Total Lymphoid Irradiation and Intrathymic Bone Marrow. Transplantation, 86(12), 1830-1836. [More Information]

2007

  • Chapman, J., Hunsicker, L., Josephson, M., Kasiske, B., Kirste, G., Leichtman, A., Munn, S., Wadstrom, J., Zhang, S., Delmonico, F., et al (2007). A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation, 83(8), S1-22. [More Information]
  • Friend, P., Russ, G., Oberbauer, R., Murgia, M., Tufveson, G., Chapman, J., Blancho, G., Mota, A., Grandaliano, G., et al (2007). Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. Transplant International, 20(9), 754-760. [More Information]
  • Vajdic, C., van Leeuwen, M., McDonald, S., McCredie, M., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2007). Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation. National Cancer Institute. Journal, 99(17), 1340-1342. [More Information]
  • Nankivell (Nankievell), B., Wavamunno, M., Borrows, R., Vitalone, M., Fung, C., Allen, R., Chapman, J., O'Connell, P. (2007). Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology. American Journal Of Transplantation, 7(2), 366-376. [More Information]
  • Chapman, J., Valantine, H., Albanell, J., Arns, W., Campistol, J., Eisen, H., Frigerio, M., Lehmkuhl, H., Marcen, R., Morris, R., Nashan, B., Pascual, J., Pohanka, E., Segovia, J., Zuckermann, A. (2007). Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. Transplantation Proceedings, 39(10), 2937-2950. [More Information]
  • Mengel, M., Chapman, J., Cosio, F., Cavaille-Coll, M., Haller, H., Halloran, P., Kirk, A., Mihatsch, M., Nankivell (Nankievell), B., Racusen, L., et al (2007). Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. American Journal Of Transplantation, 7(3), 512-517. [More Information]
  • Wavamunno, M., O'Connell, P., Vitalone, M., Fung, C., Allen, R., Chapman, J., Nankivell (Nankievell), B. (2007). Transplant Glomerulopathy: Ultrastructural Abnormalities Occur Early in Longitudinal Analysis of Protocol Biopsies. American Journal Of Transplantation, 7(12), 2757-2768. [More Information]
  • Campistol, J., Albanell, J., Arns, W., Boletis, I., Dantal, J., de Fijter, J., Mortensen, S., Neumayer, H., Oyen, O., Pascual, J., Chapman, J., et al (2007). Use of proliferation signal inhibitors in the management of post-transplant malignancies - clinical guidance. Nephrology, Dialysis, Transplantation, 22(Supp1), i36-i41. [More Information]

2006

  • Chadban, S., Campbell, S., Russ, G., Walker, R., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thompson, N., Hutchison, B., et al (2006). A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. Immunology and Cell Biology, 84(3), A6-A6.
  • Goddard, K., Pleass, H., Cross, N., O'Connell, P., Chapman, J., Nankivell (Nankievell), B., Allen, R. (2006). A twist of fate or fated to twist?
  • Vajdic, C., McDonald, S., McCredie, M., van Leeuwen, M., Stewart, J., Law, M., Chapman, J., Webster, A., Kaldor, J., Grulich, A. (2006). Cancer incidence before and after kidney transplantation. JAMA: The Journal of the American Medical Association, 296(23), 2823-2831. [More Information]
  • Nankivell (Nankievell), B., Chapman, J. (2006). Chronic Allograft Nephropathy: Current Concepts and Future Directions. Transplantation, 81(5), 643-654. [More Information]
  • O'Connell, P., Hawthorne, W., Holmes-Walker, D., Nankivell (Nankievell), B., Gunton, J., Patel, A., Walters, S., Pleass, H., Allen, R., Chapman, J. (2006). Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Medical Journal of Australia, 184(5), 221-225. [More Information]
  • Vitalone, M., Kirk, M., Allen, R., Pleass, H., Chapman, J., O'Connell, P., Nankivell (Nankievell), B. (2006). Epithelial-to-mesenchymal transition (EMT) in chronic allograft nephropathy (CAN). 84(3), A2-A2.
  • Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., et al (2006). Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation, 81(2), 202-206.
  • Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Salvadori, M., Tufveson, G. (2006). Follow-up after renal transplantation with organs from donors after cardiac death. Transplant International, 19(9), 715-719. [More Information]
  • Chapman, J. (2006). Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2. [More Information]
  • Webster, A., Ruster, L., Playford, E., Higgins, G., Chapman, J., Craig, J. (2006). IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials. 84(3), A3-A3.
  • Chapman, J. (2006). Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients. 84(3), A7-A7.
  • Salvadori, M., Rosati, A., Bertoni, E., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., et al (2006). Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: An insight from MOST, a multinational observational study. Transplantation Proceedings, 38(4), 1010-1013.
  • Chapman, J. (2006). Managing cardiovascular risk in renal transplant recipients: The role of everolimus - Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2.
  • Chapman, J. (2006). Managing cardiovascular risk in renal transplant recipients: The ruole of everolimus - Guest editor's introduction. Nephrology, Dialysis, Transplantation, 21, iii1-iii2.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation, 81(7), 953-965. [More Information]
  • Wavamunno, M., Vitalone, M., Borrows, R., Fung, C., Allen, R., O'Connell, P., Chapman, J., Nankivell (Nankievell), B. (2006). Mycophenolate mofetil reduces the histological expression of chronic allograft nephropathy. Immunology and Cell Biology, 84(3), A11-A11.
  • Chapman, J., Nankivell (Nankievell), B. (2006). Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrology, Dialysis, Transplantation, 21(8), 2060-2063. [More Information]
  • Chapman, J. (2006). Not All Donors Are Equal. Transplantation, 81(7), 976-977. [More Information]
  • Mathew, T., Chapman, J. (2006). Organ donation: a chance for Australia to do better. Medical Journal of Australia, 185(5), 245-246.
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane Database of Systematic Reviews, 19(2), CD004756-CD004756. [More Information]
  • Webster, A., Pankhurst, T., Rinaldi, F., Chapman, J., Craig, J. (2006). Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (Issue 2), 1-126. [More Information]
  • Webster, A., Craig, J., Chapman, J. (2006). Rate and relative risk of common cancers in kidney transplant recipients in Australia and New Zealand. Immunology and Cell Biology, 84(3), A13-A13.
  • Chapman, J. (2006). Scoring arteriolar hyalinosis in renal allograft biopsies: so important and yet so tricky. Nature Clinical Practice Nephrology, 2, 622-623. [More Information]
  • Eris, J., Russ, G., Hutchison, B., Walker, R., Chapman, J., Pussell, B., Mahoney, J., Campbell, S., Brault, Y., Burke, J., et al (2006). Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation. Immunology and Cell Biology, 84(3), A19-A19.
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation, 81(9), 1234-1248. [More Information]
  • Webster, A., Lee, V., Chapman, J., Craig, J. (2006). Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database of Systematic Reviews, 19(2), CD004290-CD004290. [More Information]
  • Groth, C., Chapman, J. (2006). The global alliance for transplantation. Transplantation Proceedings, 38(2), 356-357. [More Information]
  • Nankivell (Nankievell), B., Chapman, J. (2006). The Significance of Subclinical Rejection and the Value of Protocol Biopsies. American Journal Of Transplantation, 6(9), 2006-2012. [More Information]
  • Robertson, P., Allen, R., O'Connell, P., Pleass, H., Nankivell (Nankievell), B., Waugh, D., Chapman, J. (2006). Transplant beta cell function and the 'lazarus factor'. 84(3), A10-A10.
  • Chapman, J., Allen, R., Nankivell (Nankievell), B., O'Connell, P., Fung, C., Kee, T., Kable, K., Vitalone, M. (2006). Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney Transplants. Transplantation, 82(1), 36-42. [More Information]
  • Allen, R., Lau, H., Nankivell (Nankievell), B., O'Connell, P., Lennox, A., Pussell, B., Chapman, J. (2006). When all the planets are in alignment. 84 (Suppl.)(3), A22-A22.

2005

  • Wong, K., Kable, K., Hawthorne, W., Robertson, P., Chan, K., Nankivell (Nankievell), B., O'Connell, P., Chapman, J., Lau, H., Pleass, H., Allen, R. (2005). A comparison of 2 surgical techniques in pancreas transplantation. Immunology and Cell Biology, 83(4), A23-A24.
  • Verran, D., Sheridan, A., Barnwell, A., Berriman, M., Chapman, J. (2005). Biopsy of potential cadaveric renal allografts at the time of retrieval. Nephrology, 10(4), 414-417. [More Information]
  • Chapman, J., O'Connell, P., Nankivell (Nankievell), B. (2005). Chronic renal allograft dysfunction. Journal of the American Society of Nephrology, 16(10), 3015-3026. [More Information]
  • Chapman, J. (2005). Commentary: harmonizing the regulators. Transplantation, 79(6), 638-638.
  • Chapman, J. (2005). Commentary: harmonizing the regulators. Transplantation, 79(6), 638. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased Kidney Donor Suitability Guidelines. Nephrology, 10(Supplement 4), S116-S132. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased kidney donor suitability guidelines: Non-heart-beating donors. Nephrology, 10(S4), S116-S119. [More Information]
  • Lebranchu, Y., Halimi, J., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Oppenheimer, F., Pohanka, E., Salvadori, M., et al (2005). Delayed graft function: Risk factors, consequences and parameters affecting outcome - Results from MOST, a multinational observational study. Transplantation Proceedings, 37(1), 345-347.
  • OBERBAUER, R., Segoloni, G., Campistol, J., Kreis, H., MOTA, A., Lawen, J., Russ, G., Grinyo, J., Stallone, G., Hartmann, A., Chapman, J., et al (2005). Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant International, 18(1), 22-28.
  • Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Rosati, A., Salvadori, M., et al (2005). Follow-up after renal transplantation with organs from non-heartbeating donors (NHBD). American Journal Of Transplantation, 5(S11), 395-395.
  • O'Connell, P., Hawthorne, W., Simond, D., Chapman, J., Chen, Y., Patel, A., Walters, S., Burgess, J., Weston, L., Stokes, R., Moran, C., Allen, R. (2005). Genetic and Functional evaluation of the level of inbreeding of the Westran pig: a herd with potential for use in xenotransplantation. Xenotransplantation, 12(4), 308-315. [More Information]
  • Salvadori, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., et al (2005). Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: Analysis of the MOST database. Transplantation Proceedings, 37(6), 2464-2466.
  • Chapman, J. (2005). Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney International, 68(99), S108-S112. [More Information]
  • Lee, V., Chapman, J. (2005). Sirolimus: its role in nephrology. Nephrology, 10(6), 606-14. [More Information]
  • Webster, A., Woodroffe, R., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ: British Medical Journal, 331(7520), 1-11. [More Information]
  • Webster, A., Taylor, R., Chapman, J., Craig, J. (2005). Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews, (4), 1-111. [More Information]
  • Groth, C., Chapman, J. (2005). The Global Alliance for Transplantation. Transplantation, 79(9), 994-996. [More Information]
  • Wavamunno, M., Nankivell (Nankievell), B., Chapman, J., Kable, K., Allen, R., Pleass, H., O'Connell, P. (2005). The impact of screening for BK virus in renal allograft recipients. Immunology and Cell Biology, 83(4), A15-A16.
  • Chapman, J., Groth, C., Wood, K. (2005). The needs for a Global Alliance for Transplantation. Clinical Transplants, 2005, 273-279. [More Information]
  • Vitalone, M., Nankivell (Nankievell), B., Kirk, M., Allen, R., Pleass, H., Lau, H., Chapman, J., O'Connell, P. (2005). The use of gene arrays to study the pathogenesis of chronic allograft nephropathy (CAN). Immunology and Cell Biology, 83(4), A26-A26.

2004

  • Webster, A., Lee, V., Powell, J., Chapman, J., Craig, J. (2004). (O78) Tor-Inhibitors (sirolimus and everolimus) for primary immunosuppression of renal transplant recipients: A meta-analysis randomized trials. IPNA meeting, 13th Congress.
  • Webster, A., Byrne, B., McDonald, S., Craig, J., Chapman, J. (2004). (O91) Incidence, risk and predictors of cancer after renal transplantation: An analysis of ANZDATA. IPNA meeting, 13th Congress.
  • Tilden, D., Chapman, J., Davey, P., Solly, M., Crowley, S. (2004). A Decision-Analytic Economic Evaluation Of Valaciclovir Prophylaxis For The Prevention Of Cytomegalovirus Infection And Disease In Renal Transplantation. Clinical Transplantation, 18(3), 321-320.
  • Yuan, F., Watson, N., Sullivan, J., Biffin, S., Moses, J., Geczy, A., Chapman, J. (2004). Association Of Fc Gamma Receptor Iia Polymorphisms With Acute Renal-Allograft Rejection. Transplantation, 78(5), 766-769.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Chapman, J., Allen, R. (2004). Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment By Protocol Histology. Transplantation, 78(4), 557-565.
  • Chapman, J. (2004). Compliance: The Patient, The Doctor, And The Medication? Transplantation, 77(5), 782-786.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Chapman, J., Allen, R. (2004). Delta Analysis Of Posttransplantation Tubulointerstitial Damage. Transplantation, 78(3), 434-441.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2004). Evolution And Pathophysiology Of Renal-Transplant Glomerulosclerosis. Transplantation, 78(3), 461-468.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Kidney Transplant Recipients. Cochrane Database of Systematic Reviews, Jan 2004(1), CD003897.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2004). Interleukin 2 Receptor Antagonists For Renal Transplant Recipients: A Meta-Analysis Of Randomized Trials. Transplantation, 77(2), 166-176.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2004). Natural History, Risk Factors, And Impact Of Subclinical Rejection In Kidney Transplantation. Transplantation, 78(2), 242-249.
  • Nankivell (Nankievell), B., Chapman, J., Bonovas, G., Gruenewald, S. (2004). Oral Cyclosporine But Not Tacrolimus Reduces Renal Transplant Blood Flow. Transplantation, 77(9), 1457-1459.

2003

  • Chapman, J., Russ, G. (2003). Geographic variance in access to renal transplantation in Australia. Transplantation, 76(9), 1403-1406.
  • OBERBAUER, R., Kreis, H., JOHNSON, R., MOTA, A., CLAESSON, K., RUIZ, J., WILCZEK, H., JAMIESON, N., HENRIQUES, A., PACZEK, L., Chapman, J., et al (2003). Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplacnt recipients: 2-year results fo the rapamune maintenacne regimen study. Transplantation, 76(2), 364-370.
  • Chapman, J. (2003). Optimizing the long-term outcome of renal transplants: opportunities created by Sirolimus. Transplantation Proceedings, 35(3 supplement 1), 67S-72S.
  • Nankivell (Nankievell), B., Borrows, R., Fung, C., O'Connell, P., Allen, R., Chapman, J. (2003). The natural history of chronic allograft nephropathy. New England Journal of Medicine, 349(24), 2326-2333.

2002

  • Nankivell (Nankievell), B., Chapman, J., Gruenewald, S. (2002). Detection of chronic allograft nephropathy by quantitative doppler imaging. Transplantation, 74, 90-96.
  • Webster, A., Playford, E., Higgins, G., Chapman, J., Craig, J. (2002). IL2 receptor antagonists for renal transplant recipients: a systematic review of randomised controlled trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.

2001

  • Chapman, J. (2001). A different view of sensitization after renal transplant rejection? Transplantation, 71, 825-826.
  • Neal, B., Chapman, J., Chalmers, J., MacMahon, S., Girgis, S., Patel, A. (2001). Blood pressure and the vascular complications of diabetes. Medicographia, 23(3), 214-219.
  • Nankivell (Nankievell), B., Chapman, J., Gruenewald, S., Cohn,, D., Timothy, S., Evans,, S. (2001). Diagnosis of kidney transplant obstruction using Mag3 diuretic renography. Clinical Transplantation, 15, 11-18.
  • Nankivell (Nankievell), B., Fenton Lee, C., Allen, R., O'Connell, P., Chapman, J., Kuypers, D., Cheung,, E. (2001). Effect of Histological damage on long-term kidney transplant outcome. Transplantation, 71, 515-523.
  • Verran, D., deLeon, C., Chui,, A., Chapman, J. (2001). Factors in older cadaveric organ donors impacting on renal allograft outcome. Clinical Transplantation, 15, 1-5.
  • Nankivell (Nankievell), B., Fenton Lee, C., Allen, R., O'Connell, P., Chapman, J., Kuypers, D. (2001). Histological injury and renal transplant outcome: the cumulative damage hypothesis. Transplantation Proceedings, 33, 1149-1150.
  • Allen, R., Nankivell (Nankievell), B., Hawthorne, W., O'Connell, P., Chapman, J. (2001). Pancreas and islet transplantation: an unfinished journey. Transplantation Proceedings, 33, 3485-3488.
  • Chapman, J., Sheil, A., Disney, A. (2001). Recurrence of cancer after renal transplantation. Transplantation Proceedings, 33(1-2), 1830-1831.
  • Chapman, J. (2001). Sirolimus: searching for its niche or a therapy that has come of age? Transplantation, 72, 774-775.
  • Chapman, J., Robertson, P., Allen, R. (2001). Why do pancreas transplants thrombose? Transplantation, 72, 182-183.

2000

  • Hawthorne, W., Cachia, A., Walters, S., Patel, A., Clarke, J., O'Connell, P., Chapman, J., Allen, R. (2000). A large-animal model to evaluate the clinical potential of fetal pig pancreas fragment transplantation. Cell Transplantation, 9, 867-875.
  • Horton, P., Hawthorne, W., Walters, S., Patel, A., O'Connell, P., Chapman, J., Allen, R. (2000). Induction of allogenic islet tolerance in a large-animal model. Cell Transplantation, 9, 877-887.
  • Wallman, L., Stewart, G., Chapman, J., O'Connell, P., Fulcher, D. (2000). Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases. Internal Medicine Journal, 30, 712-715.
  • Pai, R., Mitchell, P., Chow, C., Chapman, J., O'Connell, P., Allen, R., Nankivell (Nankievell), B. (2000). Posttransplant cataract: lessons from kidney-pancreas transplantation. Transplantation, 69, 1108-1114.
  • Nankivell (Nankievell), B., Lau, S., Chapman, J., O'Connell, P., Fletcher, J., Allen, R. (2000). Progression of macrovascular disease after transplantation. Transplantation, 69, 574-581.

To update your profile click here. For support on your academic profile contact .